These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 739576

  • 21. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
    Hordijk GJ, Antvelink JB, Luwema RA.
    Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
    [Abstract] [Full Text] [Related]

  • 22. [Specific hyposensitization with pyridine extracts precipitated with aluminum. I. Therapeutic results].
    Basomba A, Peláez A, Villalmanzo IG.
    Allergol Immunopathol (Madr); 1974; 2(3):153-62. PubMed ID: 4418370
    [No Abstract] [Full Text] [Related]

  • 23. Hyposensitization for hay fever.
    Blair H.
    Clin Allergy; 1977 May; 7(3):291-4. PubMed ID: 908127
    [No Abstract] [Full Text] [Related]

  • 24. Hyposensitization in ragweed pollinosis.
    Speer F, Carrasco LC.
    Ann Allergy; 1976 Dec; 37(6):391-7. PubMed ID: 999058
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ, Powell RJ, Corrigan CJ, Durham SR, UK Immunotherapy Study Group.
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [Abstract] [Full Text] [Related]

  • 26. [Peroral specific hyposensitization of children with pollinosis].
    Kruglyĭ IM, Khalitova RG, Goncharova ER, Sharipova BS.
    Vestn Otorinolaringol; 1983 Feb; (1):70-3. PubMed ID: 6829124
    [No Abstract] [Full Text] [Related]

  • 27. Studies in pollen allergy. II. Comparison of leucocyte sensitivity and levels of blocking antibody in hay fever subjects administered allpyral or pollaccine.
    Weinstock M, Starr MS.
    Int Arch Allergy Appl Immunol; 1970 Feb; 37(4):385-92. PubMed ID: 4188972
    [No Abstract] [Full Text] [Related]

  • 28. The patient self (P-S) test. Demonstration of a rise in blocking antibodies after treatment with Allpyral.
    Munro-Ashman D, McEwen H, Feinberg JG.
    Int Arch Allergy Appl Immunol; 1971 Feb; 40(3):448-53. PubMed ID: 5546865
    [No Abstract] [Full Text] [Related]

  • 29. [Comparison of 3 types of immunotherapy for treating grass pollen-induced allergic rhinitis].
    Hébert J, Bédard PM.
    Allerg Immunol (Paris); 1986 Sep; 18(7):19-23. PubMed ID: 3453720
    [Abstract] [Full Text] [Related]

  • 30. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study.
    Giovannini M, Braccioni F, Sella G, Contoli M, Perri G, Frati F, Incorvaia C.
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):69-71. PubMed ID: 15859367
    [Abstract] [Full Text] [Related]

  • 31. Studies in pollen allergy. 3. The relationship between blocking antibody levels and symptomatic relief following hyposensitisation with allpyral in hay fever subjects.
    Starr MS, Weinstock M.
    Int Arch Allergy Appl Immunol; 1970 Feb; 38(5):514-21. PubMed ID: 4191851
    [No Abstract] [Full Text] [Related]

  • 32. [Hyposensitization with cross-reacting pollen allergens].
    Karl S, Rakoski J.
    Z Hautkr; 1988 Feb; 63 Suppl 4():55-7. PubMed ID: 3252627
    [Abstract] [Full Text] [Related]

  • 33. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H, White P, Annila I, Poole J, Andre C, Frew A.
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [Abstract] [Full Text] [Related]

  • 34. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C, Andersson M, Persson C, Schrewelius C, Greiff L.
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [Abstract] [Full Text] [Related]

  • 35. Clinical evaluation of hyposensitization in allergic rhinitis: comparison of the results obtained with three different extracts. Material from a 3-year study.
    Verstraeten JM, Verstraeten AF.
    Ann Allergy; 1987 Jun; 58(6):416-20. PubMed ID: 3592311
    [Abstract] [Full Text] [Related]

  • 36. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978].
    Wüthrich B, Häfner G.
    Schweiz Med Wochenschr; 1980 Feb 23; 110(8):281-90. PubMed ID: 7367848
    [Abstract] [Full Text] [Related]

  • 37. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S, Heinrich C, Scheynius A.
    Allergy; 2005 May 23; 60(5):643-9. PubMed ID: 15813810
    [Abstract] [Full Text] [Related]

  • 38. Observations on the treatment of seasonal rhinitis with chemically modified pollen allergen.
    Cooper BS.
    Br J Clin Pract; 1976 May 23; 30(11-12):217-20. PubMed ID: 827303
    [No Abstract] [Full Text] [Related]

  • 39. [Diagnosis and specific hyposensitization of pollen rhinopathy (hay fever)].
    Ushakova TA, Titova SM.
    Vestn Otorinolaringol; 1973 May 23; 35(1):25-8. PubMed ID: 4781543
    [No Abstract] [Full Text] [Related]

  • 40. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C, Monzón S, Venturini M, Lezaun A.
    J Allergy Clin Immunol; 2006 Apr 23; 117(4):810-6. PubMed ID: 16630938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.